VistaGen Therapeutics , Inc. (VTGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

VistaGen Therapeutics , Inc. (VTGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

VistaGen Therapeutics , Inc. (VTGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
VistaGen Therapeutics , Inc. (VTGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
31 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

VistaGen Therapeutics , Inc. (VistaGen) is a clinical-stage biopharmaceutical company that specializes in drug development, rescue and discovery and regenerative medicine. The company produces human heart cells and liver cells by using its proprietary human pluripotent stems cell technology. The companys pipeline product portfolio comrpise AV-101, which is a prodrug candidate used in the treatment of central nervous system disorders such as major depressive disorder, refractory epilepsy, chronic neuropathic pain and Parkinsons disease.

VistaGen Therapeutics , Inc. (VTGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal fin

  
Source:
Document ID
GDPH123122D
Country
Industry
Ticker
VTGN=US
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
VistaGen Therapeutics , Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
VistaGen Therapeutics , Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
VistaGen Therapeutics , Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
VistaGen Therapeutics , Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
VistaGen Therapeutics , Inc., Medical Devices Deals, 2010 to YTD 201691
VistaGen Therapeutics , Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
VistaGen Therapeutics , Inc., Pharmaceuticals &Healthcare, Deal Details1117
  Partnerships111
    VistaGen Therapeutics Enters into R&D Agreement with National Institute of Mental Health112
    VistaGen Therapeutics Enters Into Agreement With Celsis In Vitro Technologies131
    VistaGen Therapeutics Enters Into Research Agreement With Duke University141
    VistaGen Therapeutics Expands Research And Development Agreement With University Health Network152
  Licensing Agreements171
    VistaGen Therapeutics Enters into Licensing Agreement with University Health Network171
    VistaGen Therapeutics Enters Into Licensing Agreement With McEwen Centre for Regenerative Medicine181
  Equity Offering191
    VistaGen Therapeutics Raises USD10 Million in Public Offering of Shares and Warrants192
    VistaGen Therapeutics Raises USD1.6 Million in Private Placement of Securities211
    VistaGen Therapeutics Completes First Tranche Of Private Placement Of Shares For US$0.025 Million221
    VistaGen Completes Private Placement Of US$2.87 Million231
  Debt Offering241
    VistaGen Therapeutics Raises USD3 Million in Private Placement of 10% Notes241
    VistaGen Therapeutics Raises USD1 Million in Private Placement of 10% Notes251
  Acquisition261
    Excaliber Completes Acquisition Of VistaGen In Reverse Acquisition262
VistaGen Therapeutics , Inc. - Key Competitors281
Key Employees291
Locations And Subsidiaries301
  Head Office301
Appendix311
  Methodology311
  About GlobalData311
  Contact Us311
  Disclaimer311

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "VistaGen Therapeutics , Inc. (VTGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/VistaGen-Therapeutics-Inc-VTGN-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6673>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). VistaGen Therapeutics , Inc. (VTGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/VistaGen-Therapeutics-Inc-VTGN-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6673>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research